Biologic therapy is associated with malignancies among Israeli patients with rheumatoid arthritis: A population-based study.

Ella Katony Eizenstat,Fadi Hassan, Avivit Golan Cohen,Eugene Merzon,Ilan Green,Ziv Paz,Mohammad E Naffaa

International journal of rheumatic diseases（2023）

引用 0|浏览6

暂无评分

摘要

Biologic DMARDs are associated with increased risk of malignancy among Israeli RA patients, presumably contributed by MSC and NMSC. MSC was the most prevalent type of malignancy in this cohort and may indicate a predisposition state among Israeli RA patients.

查看译文

关键词

biologic therapy, malignancy, melanoma skin cancer, rheumatoid arthritis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要